The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Increased detection of suspected atrial fibrillation in elderly and female hypertensive patients through home blood pressure monitoring: the HOME-AF study
Open accessAbstract
BACKGROUND: Episodes of suspected atrial fibrillation are particularly frequent in essential hypertension. This study aimed to investigate the incidence of new suspected atrial fibrillation cases detected through home blood pressure (BP) screening among hypertensive patients. Association of new suspected atrial fibrillation cases with arterial hypertension (AH) phenotypes and the CHA2DS2-VASc score was also investigated. METHODS: The prospective study recruited hypertensive patients at least 50 years old from private and hospital hypertensive clinics. An ECG was performed during the first visit. Microlife BP A6 PC was used to measure office and home BP for at least 3 and preferably 7 consecutive days. RESULTS: A total of 2408 AH patients were recruited. Suspected atrial fibrillation was detected by BP monitor in 12.5% of patients. CHA2DS2-VASc was greater in hypertensive patients with suspected atrial fibrillation detection, as compared with all other hypertensive patients (3.3 ± 1.4 vs. 2.8 ± 1.4, P < 0.0001). Suspected atrial fibrillation detection was associated with advanced age (≥ 75 years, P < 0.0001) and female sex (P = 0.01). A nonsignificant association between suspected atrial fibrillation detection and history of chronic heart failure/left ventricular dysfunction was observed (P = 0.06). In the multivariate analysis, age and sex were the only independent risk factors with patients at least 75 years old having more than twice the risk of suspected atrial fibrillation compared with patients less than 64 years old. No differences between new suspected atrial fibrillation cases and AH phenotype (white coat/uncontrolled/masked hypertension) were identified. CONCLUSION: In our cohort of hypertensive patients, suspected atrial fibrillation was common particularly among elderly and female patients. These results underline the need for early suspected atrial fibrillation detection to minimize the increased thromboembolic risk associated with hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An invasive study in atrial fibrillation patients with high ventricular rate showed that there is larger underestimation of oscillometric SBP compared with intra-aortic measurement [216].”
Citations
Cites
Manolis, A. J., Rosei, E. A., Coca, A., Cifkova, R., Erdine, S. E., Kjeldsen, S., Lip, G. Y. H., Narkiewicz, K., Parati, G., Redon, J., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f03bf · Cited by 198
Self-citationWiesel, J., Abraham, S., & Messineo, F. C. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.331 · Cited by 58
Flagged first, then by citations
Research works printed but not linked: 21
- Hollander, 1976, Role of hypertension in atherosclerosis and cardiovascular disease, Am J Cardiol, 38, 786, 10.1016/0002-9149(76)90357-X · DOI
- Kannel, 1998, Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates, Am J Cardiol, 82, 2N, 10.1016/S0002-9149(98)00583-9 · DOI · Paper page
- Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, 22, 983, 10.1161/01.STR.22.8.983 · DOI · Paper page
- Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Europace, 18, 1609, 10.1093/europace/euw295 · DOI
- Levin, 2015, A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke, Europace, 17, 207, 10.1093/europace/euu213 · DOI · Paper page
- Mairesse, 2017, Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE), Europace, 19, 1589, 10.1093/europace/eux177 · DOI
- Chan, 2017, Head-to-head comparison of the alivecor heart monitor and microlife watchBP Office AFIB for atrial fibrillation screening in a primary care setting, Circulation, 135, 110, 10.1161/CIRCULATIONAHA.116.024439 · DOI · Paper page
- Wiesel, 2009, Detection of atrial fibrillation using a modified Microlife blood pressure monitor, Am J Hypertens, 22, 848, 10.1038/ajh.2009.98 · DOI
- Stergiou, 2009, Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation, J Hum Hyperten, 23, 654, 10.1038/jhh.2009.5 · DOI
- Verberk, 2016, Screening for atrial fibrillation with automated blood pressure measurement: research evidence and practice recommendations, Int J Cardiol, 203, 465, 10.1016/j.ijcard.2015.10.182 · DOI
- Mancia, 2013, 2013 ESH/ESC guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens, 31, 1925, 10.1097/HJH.0b013e328364ca4c · DOI
- Marazzi, 2012, Comparison of Microlife BP A200 Plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients, Adv Ther, 29, 64, 10.1007/s12325-011-0087-0 · DOI
- Benjamin, 1994, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study, JAMA, 271, 840, 10.1001/jama.1994.03510350050036 · DOI · Paper page
- Chan, 2017, Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting, BMJ Open, 7, e01368, 10.1136/bmjopen-2016-013685 · DOI
- Wasmer, 2017, Predisposing factors for atrial fibrillation in the elderly, J Geriatr Cardiol, 14, 179
- Odening, 2019, Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling, Europace, 21, 366, 10.1093/europace/euy215 · DOI
- Pothineni, 2018, Gender and atrial fibrillation: differences and disparities, US Cardiol Rev, 12, 103, 10.15420/usc.2017:39:1 · DOI
- Proietti, 2016, Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: the AFFIRM Trial, Int J Cardiol, 207, 258, 10.1016/j.ijcard.2016.01.169 · DOI
- Díez, 2010, A translational approach to hypertensive heart disease, Hypertension, 55, 1, 10.1161/HYPERTENSIONAHA.109.141887 · DOI
- E Darby, 2014, Management of atrial fibrillation in patients with heart failure, J Atr Fibrillation, 7, 1105
- Williams, 2018, 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension, J Hypertens, 36, 1953, 10.1097/HJH.0000000000001940 · DOI · Paper page
Cited by
Sorted by citations
Parati, G., Stergiou, G. S., Bilo, G., Kollias, A., Pengo, M., Ochoa, J. E., Agarwal, R., Asayama, K., Asmar, R., Burnier, M., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002922 · Cited by 178
Metadata
- Authors
- Savvari, P., Triantafyllidi, H., Skiadas, J., Kalogeropoulos, P., Menegas, D., Manolis, A., Papoulidis, N., Andrikopoulos, G., & Tsioufis, K.
- Affiliations
- Pfizer (United States) (US)
- National and Kapodistrian University of Athens (GR)
- Hospital Agioi Anargyroi (GR)
- Cardiology Department, Asklipion General Hospital, Athens
- Cardiology Department, Kavala General Hospital, Kavala
- Henry Dunant Hospital (GR)
- Corresponding author
- Savvari, Paraskevi
- ORCID
- Venue
- Journal of Hypertension
- Published
- 2020-03
- Volume
- 38
- Issue
- 3
- Pages
- 441-447
- ISSN
- 0263-6352 (ISSN-L)
- 1473-5598
- OpenAlex
- W2981566345
- Cited by
- 6
- References
- 2
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2021: 1
- FWCI
- 0.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hypertension (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- atrial fibrillation, essential hypertension, home blood pressure monitoring, elderly patients, female sex, CHA2DS2-VASc score, hypertension phenotypes, white coat hypertension, masked hypertension, uncontrolled hypertension, thromboembolic risk
- MeSH terms
- Aged, Atrial Fibrillation, Blood Pressure Determination, Female, Home Care Services, Humans, Hypertension, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
